The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.
A failed trial for a heart drug casts shadow over rivals developing similar therapies
MA
MarketWatch Top StoriesBy Jaimy Lee
EXECUTIVE SUMMARY
The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.
Key Takeaways
- A failed trial for a heart drug casts shadow over rivals developing similar therapies.
- The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.
- The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.
Read Complete Original Article
Published originally on MarketWatch Top Stories
